About 265,000 results
Behind the rise BMS’ Cobenfy, the first new schizophrenia drug in ...
BMS’ KarXT nears schizophrenia approval, but AbbVie and
Schizophrenia Treatment Revolution: FDA Approves Bristol Myers …
Bristol Myers Squibb - Bristol Myers Squibb Completes Acquisition …
Bristol-Myers Squibb: Unlocking Value With KarXT FDA Approval …
Bristol Myers Squibb Reveals Promising Data for KarXT, a
Bristol Myers Squibb - Bristol Myers Squibb Presents New Interim …
Schizophrenia drug KarXT wins FDA approval - The Columbus …
Schizophrenia Space Anticipates First-in-Class FDA Approval for …
BMS wagers $14bn on Karuna’s schizophrenia drug